At what enterprise value was KLINGEL MEDICAL GROUP acquired in 2023?

During the acquisition of KLINGEL MEDICAL GROUP by ELOS MEDTECH in 2023, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of KLINGEL MEDICAL GROUP when it was acquired by ELOS MEDTECH?

The estimated EV/EBITDA multiple for KLINGEL MEDICAL GROUP is in the range of 10x - 18x.

When was KLINGEL MEDICAL GROUP acquired by ELOS MEDTECH?

KLINGEL MEDICAL GROUP was acquired by ELOS MEDTECH in 2023.

What was the revenue of KLINGEL MEDICAL GROUP at the time of the deal?

The revenue of KLINGEL MEDICAL GROUP at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of KLINGEL MEDICAL GROUP during the acquisition?

KLINGEL MEDICAL GROUP's EBITDA is estimated to be in the range of 10M - 30M EUR.

How is the data for the KLINGEL MEDICAL GROUP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the KLINGEL MEDICAL GROUP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.wengervieli.ch/en-us/news/deal-ik-partners-sells-klingel-medical-group-to-elos-medtech-ab

← DATABASE

Home Database Healthcare & PharmaKLINGEL MEDICAL GROUP

07/2023

KLINGEL MEDICAL GROUP acquired by ELOS MEDTECH

GERMANY Life Sciences / Medical Devices / Implants & Prosthetics EV 300M - 700M EUR

Context

Elos Medtech entered into an agreement to acquire 100% of Klingel Medical Group from IK Partners and its management team. The strategic rationale for the deal is to create a market-leading European MedTech CDMO with significantly enhanced R&D capabilities and a broader technological offering. The acquisition expands Elos Medtech's industrial presence in the DACH region by adding eight specialized manufacturing sites in Germany and Switzerland. Strategically, the combination aims to unlock cross-selling opportunities and provides Klingel with increased visibility and distribution channels in the U.S. market. This milestone consolidation allows the combined entity to leverage a global footprint to drive operational improvements and cater to the unique needs of international OEM customers in the medical device sector.

KLINGEL MEDICAL GROUP, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 1922, Klingel Medical Group is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in high-precision metal products for the medical technology sector. The company's business model focuses on the end-to-end production of complex components and medical devices, utilizing advanced CNC milling, turning, and cleanroom assembly. Its value proposition is anchored in extensive R&D capabilities and specialized technological expertise required for surgical instruments and implants. Strategically, the firm operates as a mission-critical partner for global medical OEMs, maintaining eight production facilities across Germany and Switzerland with approximately 900 employees. By providing a "one-stop-shop" service for the orthopedics, spine, and dental markets, the organization has established a dominant footprint in the DACH region.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
08/2023	CARL ZEISS MEDITEC	D.O.R.C. (DUTCH OPHTHALMIC RESEARCH CENTER)	NETHERLANDS	Medical Devices
08/2023	OAKLEY CAPITAL INVESTMENTS	LIBERTY DENTAL GROUP	GERMANY	Implants & Prosthetics
07/2023	EQT PARTNERS / ADIA	DECHRA PHARMACEUTICALS	UNITED KINGDOM	Pharma & Biotech
07/2023	LAUXERA	ORGANOX	UNITED KINGDOM	Medical Devices
06/2023	NOVO NORDISK	BIOCORP	FRANCE	Medical Devices
04/2023	SARTORIUS	POLYPLUS	FRANCE	R&D Biotech
04/2023	HALMA	APRIOMED	SWEDEN	Medical Devices
04/2023	Innovad Group	Herbonis	SWITZERLAND	Animal Health
02/2023	ARDIAN	THERADIAL	FRANCE	Medical Devices
01/2023	Dermapharm	Arkopharma	FRANCE	Nutrition & Dietary Supplements

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of KLINGEL MEDICAL GROUP by ELOS MEDTECH are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.